diabetic nephropathy type 2
Showing 1 - 20 of 20
Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Acetylsalicylic Acid
- Placebo
- (no location specified)
Sep 28, 2023
Technology and Clinical Transformation of Type 2 Diabetes
Recruiting
- Diabetic Nephropathy Type 2
- +2 more
-
Beijing, ChinaChinese PLA General Hospital
May 25, 2023
Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Tadalafil 20Mg Oral Tablet
- Pentoxifylline 400 MG Oral Tablet
- (no location specified)
Aug 2, 2022
Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Empagliflozin 25 MG
- Enalapril Maleate 20 mg
- (no location specified)
May 9, 2022
Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes, Type 2 Trial in Rochester (Autologous adipose-derived mesenchymal
Recruiting
- Diabetic Kidney Disease
- +7 more
- Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
- Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 11, 2022
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in
Completed
- Sleep Apnea
- +6 more
-
Aarhus, DenmarkAarhus University Hospital
Feb 4, 2022
Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 Trial in Lawrenceville, Bethlehem (Renin-Angiotensin (RAAS) alone,
Recruiting
- Renal Insufficiency, Chronic
- Diabetic Nephropathy Type 2
- Renin-Angiotensin (RAAS) alone
- Renin-Angiotensin (RAAS) blockers in combination with Spironolactone
-
Lawrenceville, Georgia
- +1 more
Jan 26, 2022
Diabetic Nephropathy Type 2 Trial in Milano (Comparison of eGFR values and ketonemia in diabetic patients)
Active, not recruiting
- Diabetic Nephropathy Type 2
- Comparison of eGFR values and ketonemia in diabetic patients
-
Milano, ItalyASST FBF-Sacco P.O. Sacco/Fatebenefratelli e Oftalmico
Sep 27, 2021
Diabetic Nephropathy Type 2, Biomarker Trial in Hangzhou
Recruiting
- Diabetic Nephropathy Type 2
- Biomarker
-
Hangzhou, Chinathe Second Affiliated Hospital Zhejiang University Schoolof Medi
Jul 14, 2021
Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
Not yet recruiting
- Diabetic Nephropathy Type 2
- Enzyme linked immunosorbent assay
- (no location specified)
Jul 4, 2021
Diabetic Nephropathy Type 2 Trial in Shanghai (ShenqiDihuang Decoction, ShenqiDihuang Decoction )
Recruiting
- Diabetic Nephropathy Type 2
- ShenqiDihuang Decoction
- ShenqiDihuang Decoction placebo
-
Shanghai, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Med
Mar 16, 2021
Diabetic Nephropathy Type 2 Trial in Shanghai (HuangQi Decoction, HuangQi Decoction )
Recruiting
- Diabetic Nephropathy Type 2
- HuangQi Decoction
- HuangQi Decoction placebo
-
Shanghai, Shanghai, ChinaLonghua Hospital, Shanghai University of Traditional Chinese Med
Mar 16, 2021
Diabetic Nephropathy Type 2, Albuminuria, Type2 Diabetes Trial in Leiden (Fasting mimicking diet Prolon, Food supplement
Completed
- Diabetic Nephropathy Type 2
- +9 more
- Fasting mimicking diet Prolon
- +2 more
-
Leiden, Noord Holland, NetherlandsLeiden Universitiy Medical Center (LUMC)
Feb 17, 2021
Persons With Type 2 Diabetes on Haemodialysis
Completed
- Diabetic Nephropathy Type 2
- Type2 Diabetes
- Continuous glucose monitoring
- +3 more
-
København Ø, DenmarkRigshospitalet
Jun 29, 2020
Diabetic Nephropathy Type 2, Microalbuminuria Due to Type 2 Diabetes Trial in Bani Suwayf (Tritace (Ramipril 10 mg))
Unknown status
- Diabetic Nephropathy Type 2
- Microalbuminuria Due to Type 2 Diabetes Mellitus
- Tritace (Ramipril 10 mg)
-
Banī Suwayf, EgyptFaculty of Medicine,Beni-Suef University
Jan 14, 2020
Diabetic Nephropathy Type 2 Trial in Guadalajara (green tea extract, Placebo)
Unknown status
- Diabetic Nephropathy Type 2
- green tea extract
- Placebo
-
Guadalajara, Jalisco, MexicoInstitute of Experimental and Clinical Therapeutics (INTEC), CUC
Feb 19, 2019
Diabetic Nephropathy Type 2 Trial in Gentofte (Linagliptin, Empagliflozin, Telmisartan)
Withdrawn
- Diabetic Nephropathy Type 2
- Linagliptin
- +3 more
-
Gentofte, DenmarkSteno Diabetes Center Copenhagen
Sep 12, 2018
T-regulatory Cells in Diabetic Type Two Nephropathy
Unknown status
- Diabetic Nephropathy Type 2
- laboratory test
- (no location specified)
Jul 8, 2018
Diabetic Nephropathy Type 2 Trial in Kaohsiung (Extracorporeal low-intensity shockwave)
Unknown status
- Diabetic Nephropathy Type 2
- Extracorporeal low-intensity shockwave
-
Kaohsiung, Please Select, TaiwanKaohsiung Chang-Gung Memorial Hospital
Feb 22, 2018